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Summary.-The distribution and clearance of misonidazole (MIS=Ro-07-0582) were
studied in C57 mouse tissues and in transplants of Lewis lung tumour. The half life
of the drug in blood after a dose of 1 mg/g i.p. was 3 h. Some tissues, such as liver,
were found to have consistently low MIS levels, and this was found to be due to
degradation of the drug after removal of the tissues from the host.
The in vivo cytotoxicity of MIS to Lewis lung tumour cells was studied using an
in-vitro colony assay. After half of the tumours had been irradiated with 10 Gy to kill
most of the oxic cells, the mice received i.p. injections of MIS. To simulate the longer
drug exposure of human tumour cells (due to the longer half life in man) a repeated
injection regime was used in some mice. There was no significant cell kill after a
single dose, but with a prolonged exposure to the drug in the multiply injected
animals, cell survival was reduced to 50o% of control in both the irradiated and
unirradiated tumours. Since the hypoxic fraction of the unirradiated tumour is
probably not more than30o%, it would appear that MIS is not selectively cytotoxic to
hypoxic cells. However, MIS had a much greater cytotoxic effect upon hypoxic Lewis
lung tumour cells in vitro, with very little or no effect on cells grown in air. This
would support the theory that the presence of hypoxic cells is essential for the ex-
pression of MIS cytotoxicity.
THERE is currently great interest in the
ability of the nitromidazole compound,
misonidazole (MIS: Ro-07-0582) to radio-
sensitize hypoxic tumour cells and to kill
them directly (Adams, 1977; Brown, 1977;
Hall & Roizin-Towle, 1975; Stratford &
Adams, 1977). In-vitro evidence suggests
that the cytotoxicity of MIS depends
greatly on the duration of drug exposure,
and that its rapid clearance from the
blood of mice may be the reason why few
mouse tumour cells are killed by a single
dose. Our objective in this study was to
try to simulate in the mouse the time
course of blood levels of the drug pre-
viously found in man. The level of cyto-
toxicity achievable in murine transplanted
Lewis lung tumours was also investigated.
MATERIALS AND METHODS
C57/BL mice 8-12 weeks old and weighing
18-19 g were used in these experiments.
Lewis lung tumour was transplanted as a
tumour mush into the right and left gastroc-
nemius muscles. Animals prepared in this
manner were used for in-vivo cytotoxicity
studies or for tumour and normal-tissue drug
distribution studies.
MIS was dissolved in sterile normal saline
(30 mg/ml) and injected i.p. either as a single
dose (1 mg/g) or as a multiple-dose regime.
The multiple-dose regime was designed to
simulate the concentration and half life
observed in man (Flockhart et al., 1978).
This involved the administration of a loading
dose of 03 mg/g followed every 2 h by a
maintenance dose of 0-16 mg/g. Such a
regime could be continued for 48 h, although
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some animals died after 36 h. Control mice
received i.p. injections of normal saline.
Mice were anaesthetized with Saffan or
ether. Heparin was used to coat the pipettes
used for obtaining blood. Neither anaes-
thetics nor heparin interfered with the deter-
mination of MIS concentration. The total
nitroimidazole content ofblood was measured
by differential pulse polarography (Princeton
Applied Research 174A Polarographic
Analyser) essentially according to the method
ofKane (1961). The concentration ofMIS was
measured in homogenized tissue samples
using gas-liquid chromatography according
to the method of Flockhart et al. (1978) or
high-pressure liquid chromatography accord-
ing to the method of Workman et al. (1978).
Blood was obtained either from the
axillary artery or from the tail vein with a
100 ml heparinized pipette. There was no
difference in drug concentration in blood from
either site. Drug level in whole blood was
measured after it had been established that
the concentration of MIS in serum, packed
cells, haemolysed blood and whole blood was
the same.
The in-vitro cytotoxicity studies were per-
formed when the tumours weighed 0-2 g.
In each mouse the left-hind-leg tumour was
irradiated with 60Co y rays (10 Gy) as
described by Steel et al. (1978). The right-leg
tumour and body were shielded with 15 cm
of lead, which reduced the dose to <0-1 Gy
to these areas. The temperature of the mice
was prevented from dropping below 36°C by
having them in a well-ventilated wvarm-air
enclosure throughout anaesthesia.
About 20 min after irradiation, the animals
were randomly divided into two groups and
injected i.p. with either MIS or normal
saline. To assay in-vivo cytotoxicity, 3
tumours from different animals were used for
each treatment group. The tumours were
removed from the mice 24 h after a single
dose or the first administration of a 24 h
repeated injection regime, and 48 h after the
first administration of a 2-dose or 48-h re-
peated injection regime. After removal from
the animals, tumours were processed imme-
diately to prevent the possibility of further
drug cytotoxicity in the excised tissues.
Cell survival was measured by a soft-agar-
colony assay according to Courtenay (1976).
In-vitro cytotoxicity was studied by the
technique of Stratford & Adams (1977),
modified by using the soft-agar-colony assay
of Courtenay (1976). Some tumours were
"clamped" (i.e. blood ciculation was pre-
vented by a nylon cord secured around the
upper part of the leg under a tension of 1 kg.
Steel, G. G., unpublished). Mice were killed
by asphyxiation with ether. Temperatures
were measured using the infant rectal probe
of a Light Laboratories Electric Thermo-
meter.
The drug concentrations in Lewis lung
tumours and normal tissues were found in
previous experiments to be variable. Liver,
brain and kidney had low MIS concentra-
tions. It was thought that degradation of the
drug might be occurring in tissues after re-
moval from mice, in which case the time
between tissue removal and assay could
effect the levels of drug found in tissue.
Experiments were initiated to investigate the
changes in drug concentration in tissue stored
at room temperature after excision from the
host.
Misonidazole was supplied by Dr C.
Smithen of Roche, Welwyn Garden City.
Saffon was obtained from Glaxo Labora-
tories, Brentford.
RESULTS
Drug distribution studies
The peak concentration of nitroimid-
azole in blood after an injection of the
compound (1 mg/g i.p.) was between 1000
and 1100 tg/ml and occurred 20-30 mim
after injection. The concentration then
fell, with a half-life of about 3 h (Fig. la).
The concentrations of MIS (as a per-
centage of blood concentration) in tissues
assayed immediately after removal were:
Lewis lung tumour, 380%; liver, 620%;
brain, 58%; and kidney, 58%. Thereafter
the drug concentration fell in all the
tissues, but with different half lives as
follows: liver, 30 min; kidney, 70 min;
brain, 100 min; and Lewis lung tumour,
195 min; (Fig. lb). MIS concentration was
found to be unaltered after 5 h in mouse
liver placed in liquid N2 immediately after
excision, and in whole blood stored at
room temperature.
In-vivo cytotoxicity
Mice were given MIS in various sched-
ules after one tumour in each mouse had
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been irradiated with 10 Gy. The effect on
cell survival is shown in Table I. The cyto-
toxicity observed with 1 or 2 doses oI
MIS (1 mg/g) was not significantly differ-
ent from the controls (P- 0-2 one-sided
Student's t test), nor was there any great
increase in cytotoxicity if irradiation was
used to reduce the number of viable oxic
cells before 1 or 2 doses of drug.
Table I also shows the survival of Lewis
lung tumour cells after multiple i.p. in-
a jections of drug. The administration of 13
doses in 24 h reduced the cell survival to
6 0-52 (P 0 02). Increasing the duration of
A rilc 'V,-rVtOq11VP to 4z h aravpT ninroQs %AL UV Toit CV U IIs >v11ss V
cell kill. The combined effects of 10 Gy
irradiation and multiple doses ofMIS were
simply additive.
Pilot experiments on the action of MIS
in clamped tumours showed that clamping
alone produced a large and variable drop
in viable-cell yield. Similarly when
tumour-bearing animals were killed and
maintained at 43°C for up to 3 h a 2-log
decrease in cell yield resulted. The pro-
duction of total anoxia by these methods
caused such a large reduction of tumour-
cell yield that drug-induced cytotoxicity
could not be detected.
In-vitro cytotoxicity
Lewis lung tumour cells were incubated
for 6 h with MIS (100 /tg/ml, pH 7 4,
37°C) under N2+50 CO2 using the pro-
cedure ofStratford & Adams (1977).
The results (Fig. 2) show a 3-decade
TABLE. Survivingfraction (SF) of Lewis lung tumour cells after various
dosage schedules of misonidazole (MIS)
Radiation Expecte(d
MIS alone "additive" Observe(d
Dosage* of MIS alone (10 Gy) SFt l0 Gy+MIS
Single dose 0-93 0-1 0 09 0-08
Two doses 0 79 0-08 0 06 0-08
Repeated doses for 24 h 0-52 0-1 0 05 0-05
Repeated doses for 48 h 05:3 0 08 0 04 0 04
* Single dose of MIS was I mg/g i.p. injection and assayed 24 h later. Two single doses
were 1 mg/g on 1st day followed by mg/g on 2nd day, and assayed 48 h after 1st injection.
Repeated injections were of a loading (lose of 0 33 mg/g followed evely 2 b by a main-
tenance dose of 0-16 mg/g, continued for 24 or 48 h before assaying.
Blood concentrations ranged from 60 to 118 g/ml.
The SF reported is an average of 3 experiments, each of 3 animals per point.
t The produclt of SF (lue to MIS and 10 Gy.
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reduction of cell survival. No cytotoxicity
to oxic cells (under air) was detected.
DISCUSSION
The half life of MIS in C57/BL mice
reported above is considerably longer than
the 1 0-15 h quoted by Flockhart (1978)
for WHT mice.
The longer half life should be an
advantage for in-vnivo cytotoxicity experi-
ments.
The results reported in Fig. lb indicate
rapid degradation of MIS in various
tissues which were excised and left at
room temperature. This was particularly
rapid in liver. Drug degradation after re-
moval from the host makes it necessary to
assay or freeze tissues immediately after
removal in order to obtain accurate
estimates of concentration.
Many factors influence the cytotoxicity
of nitroimidazoles. Hypoxia appears to be
necessary for cytotoxicity to be observed.
Sutherland (1974) has demonstrated pre-
ferential killing of the central cells in an
in-vitro spheroid system. Preferential
hypoxic-cell toxicity has been demon-
strated in vitro by Stratford & Adams
(1977) using Chinese hamster cells, by
Courtenay (personal communication) and
in the present work (Fig. 2).
Cytotoxicity is thought to be dependent
on the metabolic alteration of MIS in con-
trast to radiosensitization, in which the
unaltered drug is active in fixing radiation
damage. This metabolic alteration into
toxic metabolites probably occurs only
under hypoxic conditions, and these
metabolites may be able to kill both
hypoxic and oxic cells. For example, in-
vitro cytotoxicity to oxic cells can be
demonstrated when these cells are ex-
posed to the supernatant from hypoxic
cells incubated with MIS (Whitmore et al.,
1978). In-vivo cytotoxicity to both hypoxic
and oxic cells has been demonstrated in
the present experiments (Table). Up to
50%0 cytotoxicity was observed, which is
about twice the radiobiological hypoxic
fraction in Lewis lung tumour observed by
Shipley et al. (1975). Furthermore, the
fraction of cells killed was similar to that
in both the irradiated and unirradiated
tumours. These observations suggest that
in-vivo cytotoxicity is not selective to
hypoxic cells, a conclusion also reached by
Brown (1977) and Whitmore et al. (1978).
WVhitmore's results suggest that hypoxic
cells reduce the MIS nitro group, forming
one or more products which are toxic to
all cells.
The concentration of MIS achieved in
tumour cells is important, since the cyto-
toxic effect increases with concentration.
Generally, however, the time course of cell
exposure to drug is more critical than drug
concentration. This has been shown in
vitro by Stratford & Adams (1978) and in
the in-vitro and in-vivo experiments re-
ported in this paper. The tumours in mice
receiving a single dose (1 mg/g) achieved
1--
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a higher concentration of MIS but with a
shorter exposure time than those in mice
receiving multiple doses, and showed no
apparent cytotoxic decrease in surviving
fraction. A significant cytotoxicity (50%0)
was observed when the exposure time was
increased by multiple dosage, despite a
decrease in drug concentration in the
tumour.
Hyperthermia (41-42°C) significantly
enhances the cytotoxic effect of MIS in
vitro (Stratford & Adams, 1977), whilst
lowering the temperature below 37°C may
provide the tumour cells with some pro-
tection. Mouse temperatures are very
unstable, and will readily decrease when
the animals are manipulated or given
certain drugs, including MIS. The tumour
temperatures in these experiments were
often 2-3°C below normal core tempera-
tures, which could be one explanation why
little cytotoxicity was observed. Since
temperature is an important factor in
cytotoxicity, it may be possible to use
hyperthermia clinically to enhance the
cytotoxicity ofMIS.
In conclusion, these cytoxic experi-
ments demonstrate in-vivo cytotoxicity in
the Lewis lung tumour system with con-
centrations which can be achieved in man,
and when contact time is prolonged to 24
or 48 h. However, it is not possible to con-
clude that this cytotoxicity is selective for
hypoxic cells, nor do these experiments
contradict the necessity for hypoxic cells
to be present for cytotoxicity to occur.
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